Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis

Background: Adjuvant sorafenib may enhance the efficacy of transarterial radioembolization with yttrium-90 in hepatocellular carcinoma patients. The aim of this study is to assess the efficacy and safety of radioembolization plus sorafenib in comparison to radioembolization alone. Methods: Out of 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Facciorusso, Antonio, Bargellini, Irene, Cela, Marina, Cincione, Ivan, Sacco, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226318/
https://www.ncbi.nlm.nih.gov/pubmed/32272656
http://dx.doi.org/10.3390/cancers12040897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226318/
https://www.ncbi.nlm.nih.gov/pubmed/32272656
http://dx.doi.org/10.3390/cancers12040897

Ejemplares similares